SUBSCRIBE
SUBSCRIBE
News   Deals

Teva Pharmaceutical Industries Limited Eyes More Acquisitions According to CFO

May 5, 2009 | 
1 min read
Bookmark and Share

TEL AVIV, May 5 (Reuters) - Teva Pharmaceutical Industries, the world's biggest generic drugmaker, is in the market for more acquisitions following its purchase of rival Barr, Teva Chief Financial Officer Eyal Desheh said on Tuesday.

Mergers & acquisitions Asia
MORE ON THIS TOPIC
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Former Chinook Board Member Indicted for Insider Trading Related to $3.2B Novartis Buy
May 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Joint pain anatomy medical concept
Pain
Lilly Follows Vertex Into Non-Opioid Pain With up to $1B SiteOne Buy
May 27, 2025
 · 
2 min read
 · 
Annalee Armstrong
ASD autism neurodevelopmental spectrum disorder, deficits in social communication and interaction, brain with impairment, hypersensitivity and abnormalities
Neuroscience
Epilepsy Biotech Nabs up to $570M in Deal With Italy’s Angelini Plus $140M Fundraising
May 27, 2025
 · 
1 min read
 · 
Annalee Armstrong
Neurology, philosophy: connections, the development of thought and reflection, the infinite possibilities of the brain and mind. Creativity stock photo
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
May 22, 2025
 · 
4 min read
 · 
Annalee Armstrong